Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron.
Journal Information
Full Title: Virus Evol
Abbreviation: Virus Evol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest: None declared."
Funding Disclosure
Evidence found in paper:
"Funding This project was funded by the Laboratory Directed Research and Development program of Los Alamos National Laboratory under project number 20210887ER and the National Institutes of Health under U01 AI150680 and R01AI135946."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025